全文获取类型
收费全文 | 22112篇 |
免费 | 1234篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 101篇 |
儿科学 | 465篇 |
妇产科学 | 284篇 |
基础医学 | 2694篇 |
口腔科学 | 808篇 |
临床医学 | 2308篇 |
内科学 | 5132篇 |
皮肤病学 | 442篇 |
神经病学 | 2246篇 |
特种医学 | 1029篇 |
外科学 | 3520篇 |
综合类 | 159篇 |
一般理论 | 4篇 |
预防医学 | 1439篇 |
眼科学 | 164篇 |
药学 | 1432篇 |
中国医学 | 29篇 |
肿瘤学 | 1177篇 |
出版年
2023年 | 165篇 |
2022年 | 177篇 |
2021年 | 427篇 |
2020年 | 318篇 |
2019年 | 461篇 |
2018年 | 546篇 |
2017年 | 514篇 |
2016年 | 485篇 |
2015年 | 543篇 |
2014年 | 759篇 |
2013年 | 1185篇 |
2012年 | 1552篇 |
2011年 | 1493篇 |
2010年 | 928篇 |
2009年 | 876篇 |
2008年 | 1333篇 |
2007年 | 1442篇 |
2006年 | 1392篇 |
2005年 | 1343篇 |
2004年 | 1153篇 |
2003年 | 1151篇 |
2002年 | 1078篇 |
2001年 | 250篇 |
2000年 | 190篇 |
1999年 | 211篇 |
1998年 | 238篇 |
1997年 | 237篇 |
1996年 | 180篇 |
1995年 | 165篇 |
1994年 | 175篇 |
1993年 | 166篇 |
1992年 | 165篇 |
1991年 | 159篇 |
1990年 | 141篇 |
1989年 | 132篇 |
1988年 | 134篇 |
1987年 | 127篇 |
1986年 | 105篇 |
1985年 | 120篇 |
1984年 | 106篇 |
1983年 | 103篇 |
1982年 | 105篇 |
1981年 | 99篇 |
1980年 | 75篇 |
1979年 | 73篇 |
1978年 | 85篇 |
1977年 | 66篇 |
1976年 | 54篇 |
1975年 | 58篇 |
1973年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Olle Zetterström Christer Andersson Leif Eriksson ers Fredriksson Johan Friskopp Gunnar Heden Bernt Jansson Tord Lundgren Rolf Nilveus ers Olsson Stefan Renvert Lars Salonen Lars Sjöström ers Winell ers Östgren Stina Gestrelius 《Journal of clinical periodontology》1997,24(9):697-704
Abstract The aim of the present clinical trial was to test tolerability during 2 treatments with EMDOGAIN® in a large number of patients. An open, controlled study design in 10 Swedish specialist clinics was chosen, with a test group of 107 patients treated with EMDOGAIN® in connection with periodontal surgery at 2 surgical test sites per patient. The procedures were performed 2 to 6 weeks apart on one-rooted teeth with at least 4 mm deep intraosseous lesions. A control group of 33 patients underwent flap surgery without EMDOGAIN® at I comparable site. In total 214 test and 33 control surgeries were performed. Serum samples were obtained from test patients for analysis of total and specific antibody levels. 10 of the patients had samples taken before and after the first surgery. 56 other samples were taken after one treatment with EMDOGAIN®, and 63 after 2 treatments. None of the samples, not even from allergy-prone patients after 2 treatments, indicated deviations from established baseline ranges. This indicates that the immunogenic potential of EMDOGAIN® is extremely low when applied in conjunction with periodontal surgery. Comparison between the test and control groups demonstrated the same type and frequency of post-surgical experiences, i.e., reactions caused by the surgical procedure itself. Clinical probing and radiographic evaluation was performed at baseline and 8 months postsurgery. About half of the patients (44 test and 21 control) were also evaluated after 3 years. There was a significant difference between the test and control results at 8 months post surgery. and this difference had increased further at the 3 year follow-up. The 2.5–3 mm increase in attachment and bone level after treatment with EMDOGAIN® was of the same magnitude as seen in the studies with split-mouth design aiming for lest of effectiveness of EMDOGAIN®. 相似文献
2.
Male Sprague-Dawley rats dosed with N-nitrosodiethylamine (NDEA)24 h after two-thirds partial hepatectomy were treated withthe pyrethroid insecticides fenvalerate, flucythrinate or cypermethrinin the diet: for 20 weeks. Altered hepatic foci were analyzedby quantitative stereology from paraffin-embedded sections stainedfor 相似文献
3.
4.
Signe S?nderkaer Marianne Schmiegelow Henrik Carstensen Lars B?geskov Nielsen J?rn Müller Kjeld Schmiegelow 《Journal of clinical oncology》2003,21(7):1347-1351
PURPOSE: To evaluate the pattern of neurological late effects in patients who have received surgery only for a brain tumor in childhood and to identify possible risk factors for neurological sequelae. PATIENTS AND METHODS: The medical, histologic, and operative records were reviewed for 65 consecutive patients operated for a benign brain tumor from 1970 to 1997, and all patients were re-examined after a median length of follow-up of 10.7 years. Thirty-four patients had posterior fossa tumors, 22 patients had cerebral hemisphere tumors, and nine patients had midline tumors. RESULTS: At the time of follow-up, 20 patients (31%) had no neurological deficits, 22 patients (34%) had minor deficits that did not interfere with their daily life activities, and 23 patients (35%) had moderate or severe deficits such as severe ataxia, spastic paresis, seriously reduced vision, or epilepsy with more than two seizures per year. Fourteen of the 31 patients (45%) registered with ataxia preoperatively had recovered fully. Six of seven patients had persistence of a pre- or postoperatively developed hemiparesis. Thirteen of 23 patients had persistence of cranial nerve deficits that developed second to surgery. Fifty-five percent of the 18 patients with seizures at diagnosis were seizure-free at follow-up. At follow-up both ataxia and hemiparesis were significantly more frequent among females (P =.02 and P =.03, respectively). CONCLUSION: In patients who received operation as the only treatment for their brain tumor, there was a good chance of total or partial recovery of preoperative and postoperative neurological deficits, although only one third of the patients will have no long-term neurological deficits. 相似文献
5.
6.
Niclas Petri Ebba Bergman Patrik Forsell Mikael Hedeland Ulf Bondesson Lars Knutson Hans Lennern?s 《Drug metabolism and disposition》2006,34(7):1182-1189
The aim of this study in pigs was to investigate the local pharmacokinetics of fexofenadine in the intestine and liver by using the pig as a model for drug transport in the entero-hepatobiliary system. A parallel group design included seven pigs (10-12 weeks, 22.2-29.5 kg) in three groups (G1, G2, G3), and a jejunal single-pass perfusion combined with sampling from the bile duct and the portal, hepatic, and superior caval veins was performed. Fexofenadine was perfused through the jejunal segment alone (G1: 120 mg/l, total dose 24 mg) or with two different verapamil doses (G2: 175 mg/l, total dose 35 mg; and G3: 1000 mg/l, total dose 200 mg). The animals were fully anesthetized and monitored throughout the experiment. Fexofenadine had a low liver extraction (E(H); mean +/- S.E.M.), and the given doses of verapamil did not affect the E(H) (0.13 +/- 0.04, 0.16 +/- 0.03, and 0.12 +/- 0.02 for G1, G2, and G3, respectively) or biliary clearance. The E(H) for verapamil and antipyrine agreed well with human in vivo data. Verapamil did not increase the intestinal absorption of fexofenadine, even though the jejunal permeability of fexofenadine, verapamil, and antipyrine showed a tendency to increase in G2. This combined perfusion and hepatobiliary sampling method showed that verapamil did not affect the transport of fexofenadine in the intestine or liver. In this model the E(H) values for both verapamil and antipyrine were similar to the corresponding values in vivo in humans. 相似文献
7.
Hanan Morsy Mette Mogensen Lars Thrane Gregor B. E. Jemec 《Skin research and technology》2007,13(4):444-448
BACKGROUND/PURPOSE: Tattoos have become increasingly popular followed by a growing demand for tattoo removal, and yet there is little knowledge and monitoring of tattoo pigment deposition in skin layers. The purpose of this pilot study is to describe optical coherence tomography image characteristics of intradermal tattoos. METHODS: We included five black tattoos in 3 female volunteers, 39, 35 and 30 years old. In vivo imaging of tattoo pigments in the skin is possible with optical coherence tomography (OCT), a novel non-invasive, in vivo optical imaging technology with a resolution and a penetration in skin high enough for visualization of tattoo pigment in the dermis. RESULTS: In optical coherence tomography images tattoo pigments clusters appear as dark, homogenous vertical columns and structures in the papillary dermis. OCT-scanned normal skin (without tattoos) appeared to be free of this dark structure. CONCLUSION: We have demonstrated that OCT can be used to visualize clusters of light absorbing pigments in a predictable manner. 相似文献
8.
Patricia K P Burnell Lars Asking Lars Borgstr?m Steve C Nichols Bo Olsson David Prime Ian Shrubb 《Journal of aerosol medicine》2007,20(3):269-281
Magnetic resonance imaging (MRI) of the oropharyngeal region from 20 adult volunteers using four model inhalation devices (varying mouthpiece diameters, airflow resistances) and tidal breathing was carried out. Statistical analysis (convex hull method) selected 12 scans from 80 data sets representing the extremes of all dimensions in the population. Twelve physical mouth-throat models were made by stereolithography using the exact scan data. The aim was to produce models with varying dimensions to span the adult population, and to investigate if oropharyngeal dimensions affected throat retention for different delivery systems. In an in vitro analysis, the models were used to determine the retention effect of the oropharyngeal airspaces when drug aerosols were administered from four inhalation delivery systems: a pressurised metered dose inhaler (pMDI), two different dry powder inhalers (DPIs A and B), and a nebulizer. The aims of this work were to determine the key parameters governing mouth-throat retention and whether retention was dependent on the delivery system used. Characterizing the throat models by measuring 51 different dimensional variables enabled determination of the most influential variables for dose retention for each inhalation delivery system. Throat model retention was found to be dependent on the delivery system (pMDI approximately DPI(A) > DPI(B) > Neb.). The most influential variable was the total throat model volume. Throat models representing high, median, and low oropharyngeal filtration in healthy adults have been identified. 相似文献
9.
10.